Pier Capital Position In Repligen (RGEN) Was Has Boosted; Scott & Selber Trimmed Holding in Facebook (FB) by $1.33 Million as Stock Declined

August 10, 2018 - By Bridget Boland

Facebook, Inc. (NASDAQ:FB) Logo

Pier Capital Llc increased its stake in Repligen Corporation (RGEN) by 28.24% based on its latest 2018Q1 regulatory filing with the SEC. Pier Capital Llc bought 46,939 shares as the company’s stock rose 21.70% while stock markets declined. The institutional investor held 213,134 shares of the biological products (no diagnostic substances) company at the end of 2018Q1, valued at $7.71 million, up from 166,195 at the end of the previous reported quarter. Pier Capital Llc who had been investing in Repligen Corporation for a number of months, seems to be bullish on the $2.16 billion market cap company. The stock decreased 0.30% or $0.15 during the last trading session, reaching $49.35. About 122,950 shares traded. Repligen Corporation (NASDAQ:RGEN) has risen 11.84% since August 10, 2017 and is uptrending. It has underperformed by 0.73% the S&P500. Some Historical RGEN News: 19/04/2018 – DJ Repligen Corporation, Inst Holders, 1Q 2018 (RGEN); 02/05/2018 – Wells Capital Management Inc. Exits Position in Repligen; 08/05/2018 – Repligen 1Q Adj EPS 17c; 17/05/2018 – Dir Ryan Jr Gifts 900 Of Repligen Corp; 28/03/2018 Repligen Closes Above 50-Day Moving Average: Technicals; 08/05/2018 – Repligen Raises FY18 View To EPS 32c-EPS 36c; 08/05/2018 – Repligen 1Q EPS 8c; 17/05/2018 – Repligen to Participate in 15th Annual Craig-Hallum Institutional Investor Conference; 08/05/2018 – REPLIGEN CORP RGEN.O SEES FY 2018 REVENUE $182 MLN TO $188 MLN; 17/05/2018 – Repligen Presenting at Conference May 30

Scott & Selber Inc decreased its stake in Facebook Inc (FB) by 33.62% based on its latest 2018Q1 regulatory filing with the SEC. Scott & Selber Inc sold 8,346 shares as the company’s stock declined 0.01% with the market. The institutional investor held 16,482 shares of the technology company at the end of 2018Q1, valued at $2.63M, down from 24,828 at the end of the previous reported quarter. Scott & Selber Inc who had been investing in Facebook Inc for a number of months, seems to be less bullish one the $519.89 billion market cap company. The stock decreased 1.65% or $3.025 during the last trading session, reaching $180.065. About 16.75 million shares traded. Facebook, Inc. (NASDAQ:FB) has risen 21.69% since August 10, 2017 and is uptrending. It has outperformed by 9.12% the S&P500. Some Historical FB News: 09/04/2018 – Some Facebook users will see a message above that link to tell them their data may have been shared; 21/05/2018 – QUALCOMM INC – CO AND FACEBOOK EXPECT TO BEGIN TRIALS OF INTEGRATED SOLUTION MID-2019; 23/05/2018 – Facebook users unite! “Data Labour Union” launches in Netherlands; 26/03/2018 – CALIFORNIA AG BECERRA- SENT LETTER TO FACEBOOK CEO FOR ANSWERS TO REPORTS THAT PERSONAL DATA WAS PROVIDED TO THIRD PARTIES WITHOUT KNOWLEDGE OR CONSENT; 01/05/2018 – Zuckerberg Speaking at Facebook’s Annual Developer Conference; 10/04/2018 – Facebook CEO Faces Congress: Children’s Privacy Bill of Rights: Yes or No?; 26/04/2018 – Sheryl Sandberg delivered a passionate, defiant defense of Facebook’s business; 04/04/2018 – Facebook’s Mark Zuckerberg to Appear at House Committee; 03/05/2018 – Facebook’s Double Standard on Privacy: Employees Vs. the Rest of Us; 09/03/2018 – Facebook is getting exclusive rights to 25 Major League Baseball games It’s the first time Facebook has had exclusive distribution rights to games from a major sports league

Since March 8, 2018, it had 0 insider buys, and 7 selling transactions for $12.73 million activity. RYAN THOMAS F JR had sold 1,932 shares worth $85,606 on Wednesday, June 6. 16,249 shares were sold by Hunt Anthony, worth $691,016. DAWES KAREN A had sold 20,000 shares worth $835,936 on Friday, May 11. Shares for $1.07M were sold by BARTHELEMY NICOLAS.

More recent Repligen Corporation (NASDAQ:RGEN) news were published by: Seekingalpha.com which released: “Repligen Corporation (RGEN) CEO Tony Hunt on Q2 2018 Results – Earnings Call Transcript” on August 05, 2018. Also Globenewswire.com published the news titled: “Repligen Reports Second Quarter 2018 Financial Results” on August 02, 2018. Benzinga.com‘s news article titled: “The Daily Biotech Pulse: Denali’s Parkinson’s Candidate Clears Early-Stage Trials, Dexcom’s Strong Quarter” with publication date: August 02, 2018 was also an interesting one.

Among 8 analysts covering Repligen (NASDAQ:RGEN), 7 have Buy rating, 0 Sell and 1 Hold. Therefore 88% are positive. Repligen had 14 analyst reports since November 6, 2015 according to SRatingsIntel. On Friday, July 20 the stock rating was maintained by Citigroup with “Buy”. The rating was maintained by Jefferies on Tuesday, September 12 with “Hold”. The stock has “Buy” rating by Craig Hallum on Monday, February 22. The firm has “Hold” rating given on Tuesday, June 27 by Jefferies. J.P. Morgan initiated Repligen Corporation (NASDAQ:RGEN) on Tuesday, December 5 with “Buy” rating. Jefferies maintained the shares of RGEN in report on Thursday, August 3 with “Hold” rating. The firm earned “Buy” rating on Friday, December 8 by Citigroup. Jefferies maintained the stock with “Hold” rating in Thursday, June 8 report. Jefferies maintained the stock with “Hold” rating in Wednesday, October 18 report. The rating was initiated by William Blair with “Buy” on Friday, July 21.

Pier Capital Llc, which manages about $585.14 million US Long portfolio, decreased its stake in Home Bancshares Inc (NASDAQ:HOMB) by 49,904 shares to 245,819 shares, valued at $5.61M in 2018Q1, according to the filing. It also reduced its holding in Irhythm Technologies Inc by 19,435 shares in the quarter, leaving it with 94,168 shares, and cut its stake in Ishares Russell 2000 Growth (IWO).

Investors sentiment increased to 1.39 in Q1 2018. Its up 0.13, from 1.26 in 2017Q4. It increased, as 13 investors sold RGEN shares while 46 reduced holdings. 19 funds opened positions while 63 raised stakes. 35.98 million shares or 2.25% more from 35.19 million shares in 2017Q4 were reported. 12,219 were accumulated by Group Incorporated One Trading Limited Partnership. Metropolitan Life Com accumulated 0% or 12,258 shares. Bartlett Lc invested 0% in Repligen Corporation (NASDAQ:RGEN). Citigroup invested 0% in Repligen Corporation (NASDAQ:RGEN). Sector Pension Invest Board invested 0.01% in Repligen Corporation (NASDAQ:RGEN). 8,012 were accumulated by Piedmont Invest Advisors Ltd Liability. Rhumbline Advisers, Massachusetts-based fund reported 105,594 shares. Fred Alger Mgmt invested in 377,235 shares. Carroll Finance invested in 1,000 shares or 0% of the stock. Schwab Charles Mngmt holds 0.01% of its portfolio in Repligen Corporation (NASDAQ:RGEN) for 190,417 shares. 213,134 were accumulated by Pier Capital Ltd. Ubs Asset Mngmt Americas reported 18,448 shares. State Street Corporation invested 0% in Repligen Corporation (NASDAQ:RGEN). Bnp Paribas Arbitrage Sa accumulated 12,288 shares or 0% of the stock. Tci Wealth Advisors Inc invested in 82 shares.

Investors sentiment decreased to 0.87 in Q1 2018. Its down 0.34, from 1.21 in 2017Q4. It dropped, as 145 investors sold FB shares while 712 reduced holdings. 173 funds opened positions while 573 raised stakes. 1.65 billion shares or 2.41% more from 1.61 billion shares in 2017Q4 were reported. Sei Invs invested in 0.84% or 1.37M shares. Barnett & Co invested in 1,546 shares. Gemmer Asset Management Limited Liability Company has 3,733 shares for 0.21% of their portfolio. Artemis Inv Ltd Liability Partnership has 188,900 shares for 0.47% of their portfolio. Winfield stated it has 1.28% of its portfolio in Facebook, Inc. (NASDAQ:FB). California-based Ivory Invest Management Ltd Liability Company has invested 1.25% in Facebook, Inc. (NASDAQ:FB). Wealthcare Capital Mgmt Ltd Limited Liability Company has 0% invested in Facebook, Inc. (NASDAQ:FB). Haverford Tru Communications has 0.01% invested in Facebook, Inc. (NASDAQ:FB) for 4,222 shares. Massmutual Trust Communications Fsb Adv holds 0% in Facebook, Inc. (NASDAQ:FB) or 42,419 shares. Stillwater Inv Lc stated it has 31,883 shares. 15,266 were accumulated by Exane Derivatives. Hudock Cap Gp Limited has invested 0.14% of its portfolio in Facebook, Inc. (NASDAQ:FB). Jasper Ridge Ptnrs Limited Partnership owns 0.05% invested in Facebook, Inc. (NASDAQ:FB) for 4,834 shares. Birch Hill Advsrs Ltd Liability Co holds 10,534 shares or 0.14% of its portfolio. Lombard Odier Asset (Switzerland) holds 0.14% of its portfolio in Facebook, Inc. (NASDAQ:FB) for 8,321 shares.

Among 56 analysts covering Facebook (NASDAQ:FB), 50 have Buy rating, 2 Sell and 4 Hold. Therefore 89% are positive. Facebook had 291 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Overweight” rating given on Thursday, April 28 by Barclays Capital. The stock has “Buy” rating by Jefferies on Thursday, July 27. KeyBanc Capital Markets maintained Facebook, Inc. (NASDAQ:FB) on Wednesday, September 6 with “Buy” rating. The firm earned “Buy” rating on Wednesday, October 11 by Credit Suisse. UBS downgraded the stock to “Neutral” rating in Thursday, July 26 report. Credit Suisse maintained the shares of FB in report on Thursday, July 27 with “Buy” rating. The stock of Facebook, Inc. (NASDAQ:FB) has “Buy” rating given on Tuesday, March 21 by BTIG Research. The stock of Facebook, Inc. (NASDAQ:FB) has “Buy” rating given on Friday, November 6 by Argus Research. As per Friday, July 27, the company rating was downgraded by Edward Jones. The stock of Facebook, Inc. (NASDAQ:FB) earned “Outperform” rating by Credit Suisse on Monday, July 16.

Since February 12, 2018, it had 0 buys, and 100 sales for $4.63 billion activity. On Monday, May 21 Wehner David M. sold $880,309 worth of Facebook, Inc. (NASDAQ:FB) or 4,761 shares. On Thursday, June 28 Sandberg Sheryl sold $10.75 million worth of Facebook, Inc. (NASDAQ:FB) or 55,000 shares. Shares for $6.15 million were sold by Schroepfer Michael Todd. $146,055 worth of Facebook, Inc. (NASDAQ:FB) was sold by Stretch Colin on Thursday, July 5. 1.25M shares were sold by Koum Jan, worth $221.33 million on Thursday, February 15. Another trade for 10,600 shares valued at $1.96 million was sold by Cox Christopher K.

Repligen Corporation (NASDAQ:RGEN) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts